Home » Stocks » Second Sight Medical Products

Second Sight Medical Products, Inc. (EYES)

Stock Price: $0.856 USD -0.005 (-0.52%)
Updated Jul 31, 2020 4:00 PM EDT - Market closed
After-hours: $0.860 +0.004 (0.44%) Jul 31, 7:28 PM

Stock Price Chart

Key Info

Market Cap 19.79M
Revenue (ttm) 2.25M
Net Income (ttm) -32.78M
Shares Out 23.12M
EPS (ttm) -2.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 31, 2020
Last Price $0.856
Previous Close $0.861
Change ($) -0.005
Change (%) -0.52%
Day's Open 0.869
Day's Range 0.850 - 0.890
Day's Volume 199,710
52-Week Range 0.710 - 8.960

More Stats

Market Cap 19.79M
Enterprise Value 17.56M
Earnings Date (est) Aug 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 23.12M
Float 6.55M
EPS (basic) -2.13
EPS (diluted) -2.10
FCF / Share -1.91
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 589,925
Short Ratio 1.13
Short % of Float 4.85%
Beta 2.43
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 8.79
PB Ratio 4.43
Revenue 2.25M
Operating Income -33.09M
Net Income -32.78M
Free Cash Flow -29.92M
Net Cash 2.23M
Net Cash / Share 0.10
Gross Margin 54.51%
Operating Margin -1,470.01%
Profit Margin -1,456.20%
FCF Margin -1,329.19%
ROA -90.62%
ROE -240.92%
ROIC 26,066.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$10.00*
Low
10.0
Current: $0.856
High
10.0
Target: 10.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue3.386.907.963.998.953.401.571.37
Revenue Growth-51%-13.41%99.85%-55.47%163.39%117.12%14.47%-
Gross Profit1.232.012.85-6.093.66-0.16-4.06-3.03
Operating Income-33.95-35.18-28.61-33.21-20.05-21.23-18.00-16.02
Net Income-33.59-35.09-28.52-33.18-20.02-35.20-22.97-16.28
Shares Outstanding14.718.306.774.944.453.132.822.74
Earnings Per Share-2.28-4.23-4.24-6.72-4.48-11.28-8.16-5.92
Operating Cash Flow-27.63-29.81-23.95-25.07-20.55-17.09-17.43-15.32
Capital Expenditures-0.49-0.16-0.27-0.49-0.76-0.56-0.25-0.20
Free Cash Flow-28.12-29.97-24.21-25.56-21.31-17.65-17.67-15.52
Cash & Equivalents11.334.477.8410.8815.9634.628.670.00
Total Debt2.60-----19.21-
Net Cash / Debt8.734.477.8410.8815.9634.62-10.540.00
Assets16.6010.6814.5016.8128.2543.0712.67-
Liabilities9.327.606.625.667.988.4521.89-
Book Value7.283.087.8811.1520.2634.62-9.22-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Second Sight Medical Products, Inc.
Country United States
Employees 10
CEO Matthew J. Pfeffer

Stock Information

Ticker Symbol EYES
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: EYES
IPO Date November 19, 2014

Description

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. It also offers Argus II Retinal Prosthesis System for treating retinitis pigmentosa. The company was founded in 1998 and is headquartered in Sylmar, California.